Rasarfin is a novel dual Ras and ARF6 inhibitor, which blocks agonist-mediated internalization of AT1R and other GPCRs. Rasarfin also potently inhibits agonist-induced ERK1/2 signaling by GPCRs, and MAPK and Akt signaling by EGFR, as well as prevents cancer cell proliferation.

纯度：≥98%

CAS：674359-73-0